The store will not work correctly when cookies are disabled.
(R)-10-methoxy-9-methyl-3,4,11,11a-tetrahydro-1H-pyrazino[1,2-b]isoquinolin-6(2H)-one
ID: ALA2397913
PubChem CID: 71682217
Max Phase: Preclinical
Molecular Formula: C14H18N2O2
Molecular Weight: 246.31
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1c(C)ccc2c1C[C@@H]1CNCCN1C2=O
Standard InChI: InChI=1S/C14H18N2O2/c1-9-3-4-11-12(13(9)18-2)7-10-8-15-5-6-16(10)14(11)17/h3-4,10,15H,5-8H2,1-2H3/t10-/m1/s1
Standard InChI Key: ZYDTYBMBYADEAB-SNVBAGLBSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
8.1479 -4.9452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1479 -5.7702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8638 -6.1827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5755 -5.7702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5755 -4.9452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8638 -4.5327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2914 -6.1827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0072 -5.7702 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0072 -4.9452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2914 -4.5327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7189 -6.1827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4348 -5.7702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4348 -4.9452 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.7189 -4.5327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2914 -7.0077 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.0072 -4.1202 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
7.4336 -4.5324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8648 -3.7077 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.1509 -3.2942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 5 1 0
8 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 9 1 0
7 15 2 0
9 16 1 1
1 17 1 0
6 18 1 0
18 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 246.31 | Molecular Weight (Monoisotopic): 246.1368 | AlogP: 0.97 | #Rotatable Bonds: 1 |
Polar Surface Area: 41.57 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 7.56 | CX LogP: 1.19 | CX LogD: 0.80 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.80 | Np Likeness Score: 0.11 |
References
1. Zhao G, Kwon C, Bisaha SN, Stein PD, Rossi KA, Cao X, Ung T, Wu G, Hung CP, Malmstrom SE, Zhang G, Qu Q, Gan J, Keim WJ, Cullen MJ, Rohrbach KW, Devenny J, Pelleymounter MA, Miller KJ, Robl JA.. (2013) Synthesis and SAR of potent and selective tetrahydropyrazinoisoquinolinone 5-HT(2C) receptor agonists., 23 (13): [PMID:23683593] [10.1016/j.bmcl.2013.04.061] |